M. A. Omarov

M. A. Omarov

Auto-generated profile, based on publicly available information

M. A. Omarov

Pavlov First Saint-Petersburg State Medical University of Minzdrav of Russia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Siberian Medical Review
Verified
Journal Article
Closed access
AZA.M. Ziganshin
A.M. Ziganshin
BUBashkir State Medical University
Bashkir State Medical University
AYA.G. Yashchuk
A.G. Yashchuk
AMA.R. Mulykov
A.R. Mulykov
MOM.A. Omarov
M.A. Omarov
NKN.R. Khisamova
N.R. Khisamova
Th e aim of the research. To review the main factors of the adverse eff ects of alcohol on the body of the mother and the fetus. Th e review was compiled using the following databases: Scopus, MedLine, the Cochrane Library, Cyberleninka, RSCI, etc. Material and methods. The analysis of Russian and foreign scientifi c literature used the following keywords: “fetal alcoholic syndrome”, “fetal alcohol spectrum disorder”, “partial alcoholic fetal syndrome”, “alcohol-related disorder”, “neururoperative disorder associated with the prenatal effects of alcohol”, “congenital developmental defects associated with alcohol”. Th e material was compiled from the references of review articles and the selection was carried out based on the scientific value with formation of the fi nal list of literature according to the relevance of the analysed material. Results. The review presents the results of studies confi rming the adverse eff ects of alcohol on the mother’s and foetus’s organism, indicating the need to continue research to develop diagnostic criteria necessary for the diagnosis of fetal alcohol syndrome. The negative effect of alcohol intake on the fetus during intrauterine development manifesting in future neurological and behavioural disorders, mental and physical development delay, congenital defects and the stigma of facial skull dysembryogenesis has been proved. Conclusion. Numerous studies on the effect of alcohol on the mother’s and foetus’s body indicate a negative impact on the latter exerted by alcohol intake in the period of intrauterine development. All this confirms the need to improve the quality of medical care for pregnant women, the need to carry out sanitary and educational events for general practitioners, obstetricians-gynaecologists and medical staff in medical prevention and/or health facilities, as well as in families and the society as a whole.

7 March 2023 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
AZA. M. Ziganshin
A. M. Ziganshin
AMA. R. Mulyukov
A. R. Mulyukov
MOM. A. Omarov
M. A. Omarov
VMViktor A. Mudrov
Viktor A. Mudrov
RKR. Sh. Khalitova
R. Sh. Khalitova
The aim. To analyze the possibility of using the genetic mechanisms of CRISPR-Cas9 technology in the prevention and treatment of certain viral diseases.Materials and methods. The search for publications was carried out in Russian and foreign literature using the following search engines: RSCI, Cyberleninka, eLibrary, PubMed, Cochrane Library, etc. A review of domestic and international scientific papers on the research topic was carried out using search keywords: CRISPR, genetic engineering, genome editing, Cas9, sgRNA.Results. A review of using CRISPR-Cas9 method (“genetic scissors”) as a gene therapy for some viral diseases was carried out, and its main advantages and disadvantages were revealed. An analysis of the data of scientific studies on genetic research methods over the past decade discovers the main aspects of CRISPR-Cas9 technology, modern classification and prospects for using this technology in clinical practice for the treatment and prevention of human viral diseases. The possibilities of creating a more versatile and stable version of the CRISPR-Cas9 technology are considered. Particular attention is paid to the technological difficulties and obstacles that scientists face when implementing this system for targeted use in clinical medicine.Conclusion. One of the rapidly developing areas in science giving promising prospects for modern healthcare is genetic engineering, especially in cases where scientific developments are applied in clinical practice. The discovery of “genetic scissors” technology has revolutionized all medicine. Wide opportunities for developing new treatment methods for many viral diseases and creating conditions for their early prevention opened up for the medical community. In the future, with the introduction of this technology into clinical practice, it will become possible to treat diseases that have not previously responded to ongoing therapy and were considered incurable.

26 September 2023 in Molecular Genetics Microbiology and Virology (Russian version)
Verified
Journal Article
Closed access
RSRaul Ахнафович Sharipov
Raul Ахнафович Sharipov
MOM.A. Omarov
M.A. Omarov
AMA.R. Mulyukov
A.R. Mulyukov
ADA.I. Dybova
A.I. Dybova
EVE.T. Vyaseleva
E.T. Vyaseleva
EGE.A. Gubaeva
E.A. Gubaeva
The discovery of the CRISPR-Cas9 genetic scissors technology was a breakthrough in the development of gene therapy methods and attracted the attention of the entire scientific community. This technology offers promise for the treatment of many neurodegenerative and oncological diseases that were previously considered almost incurable. Today, the mechanisms of development and progression of these groups of nosologies are becoming more and more studied thanks to discoveries in the field of molecular biology and genetics. However, the application of CRISPR-Cas9 technology has some limitations and difficulties that must be taken into account. The development of gene transporters, a thorough safety assessment of modern genetic manipulation tools, and an integrated approach by experts from different fields of science will all be important to solve the problems associated with the use of CRISPR-Cas9 technology and achieve the desired therapeutic effect.

28 December 2024 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
MOM. A. Omarov
M. A. Omarov
AMA. R. Mulyukov
A. R. Mulyukov
RKR. V. Khalitov
R. V. Khalitov
SSS. I. Safarov
S. I. Safarov
GAG. U. Ayupova
G. U. Ayupova
ОЯО. Ю. Янтурина
О. Ю. Янтурина
Epigenetics plays a critical role relative to other branches of genetics, as it makes it possible to regulate gene expression without changing the nucleotide sequence of DNA molecules. This process allows cells to respond to external signals and adapt to changes in the environment while keeping their genetic information intact. The main mechanisms of epigenetic regulation include DNA methylation, posttranslational modifications of histones, chromatin remodeling and regulation through non-coding RNAs. These processes play a key role in fundamental biological processes such as cellular differentiation, organismal development, and adaptation to environmental conditions.Disturbances in epigenetic mechanisms can lead to various pathologies, including cancer, neurological and autoimmune diseases. Understanding the mechanisms of epigenetic regulation opens new avenues for the development of targeted therapies that can correct abnormal epigenetic profiles without changing the DNA structure itself.In recent years, the development and application of innovative technologies, such as the CRISPR/Cas9 genome editing system, have significantly expanded the ability to study epigenetic mechanisms and their relationship with diseases. These technologies allow not only a deeper understanding of epigenetic changes, but also the development of new therapeutic approaches, especially in the field of oncology. Research in epigenetics is also focusing on the interaction between epigenetic changes and the immune system, which opens new perspectives for the development of immunotherapies. The search for new markers of epigenetic disorders and therapeutic agents may lead to the development of individualized treatments that take into account the unique epigenetic profile of each patient.The role of epigenetic modifications in the development of diseases and the creation of new therapeutic strategies cannot be overestimated. Recent research in this area is revealing the potential of epigenetic approaches to treat a wide range of diseases, ushering in a new era in medicine where understanding and correcting epigenetic changes will be the key to effective treatment.

30 October 2024 in Siberian Scientific Medical Journal
Verified
Journal Article
Open access
PDF file
MOM. A. Omarov
M. A. Omarov
AMA. R. Mulyukov
A. R. Mulyukov
IBI. A. Burmistrov
I. A. Burmistrov
EAE. I. Akhmadishin
E. I. Akhmadishin
MLM. S. Lapteva
M. S. Lapteva
MKM. R. Kurbanadamov
M. R. Kurbanadamov
Small supernumerary marker chromosomes (sSMCs) are structurally abnormal chromosomes that cannot be clearly identified or characterized by traditional karyotyping. They can appear in a variety of forms, including rings, centric fragments, and other structural abnormalities, and are often detected during prenatal diagnosis. sSMCs occur in approximately 0.075 % of unselected prenatal cases and can be associated with a wide range of phenotypic presentations, from normal development to severe congenital malformations and syndromes. Understanding and interpreting the clinical significance of sSMCs remains challenging in genetic counseling due to their high heterogeneity and potential impact on fetal phenotype. Advances in the field of molecular cytogenetics, including techniques such as fluorescence in situ hybridization (FISH), as well as microarray comparative genomic hybridization (aCGH) and next-generation sequencing (NGS), have significantly improved the ability to accurately characterize sSMCs. These methods can determine their origin, size and genetic content, which is critical for risk assessment and decision-making during pregnancy. Thus, modern molecular cytogenetics techniques play a key role in the identification and characterization of sSMC, allowing for more accurate genetic counseling and helping to make informed pregnancy decisions. However, despite technological advances, sSMCs continue to pose a challenge for prenatal diagnosis due to their complexity and potential impact on fetal development. In this article, we aim to provide a general overview of sSMCs and of their impact on prenatal diagnosis, as well as consider the clinical significance and potential impact of sSMCs on pregnancy outcome.

30 August 2026 in Siberian Scientific Medical Journal
Verified
Journal Article
Open access
PDF file
MOM. A. Omarov
M. A. Omarov
EKE. I. Karacheva
E. I. Karacheva
MAM. M. Arapieva
M. M. Arapieva
KUK. S. Ulyumdzhiev
K. S. Ulyumdzhiev
VDV. A. Deiko
V. A. Deiko
ИБИ. М. Батыршин
И. М. Батыршин
The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology is a cutting-edge genome editing tool based on the adaptive immune mechanism of prokaryotes. This system, which operates through three key stages‒adaptation, expression, and interference‒offers high precision and efficiency in genetic modification. This article explores the mechanisms of CRISPR/Cas action and its applications in hematologic malignancies, breast cancer, colorectal cancer, gastric cancer, and lung cancer. Genome editing has demonstrated significant effectiveness in suppressing tumor growth, enhancing cellular sensitivity to therapy, and developing personalized treatment approaches. CRISPR/Cas enhances the efficacy of Chimeric Antigen Receptor T-cell Therapy (CAR-T) and helps overcome tumor cell resistance to treatment. The technology is also actively utilized in genetic screening to identify gene functions and discover new therapeutic targets. However, several challenges remain, including off-target effects, immune responses, and difficulties in delivering CRISPR components to target cells. This article discusses promising strategies to overcome these limitations, such as the development of novel Cas protein variants, improved delivery methods, and epigenetic approaches. CRISPR/Cas represents one of the most promising tools in molecular biology, providing the ability to precisely investigate gene functions and to develop new experimental strategies for therapeutic intervention. The potential of this technology is defined by its flexibility and applicability across a wide range of tasks‒including target validation, disease modeling, and the generation of advanced cellular products. However, its full integration into clinical practice requires further studies aimed at improving safety, reducing the frequency of unintended effects, and developing reliable delivery systems.